US 6737511
Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
expired A61KA61K38/00A61K39/00
Quick answer
US patent 6737511 (Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61K39/00, A61P, A61P43/00